We conducted a three-stage genetic study to identify susceptibility loci for type 2 diabetes (T2D) in east Asian populations. We followed our stage 1 meta-analysis of eight T2D genome-wide association studies (6,952 cases with T2D and 11,865 controls) with a stage 2 in silico replication analysis (5,843 cases and 4,574 controls) and a stage 3 de novo replication analysis (12,284 cases and 13,172 controls). The combined analysis identified eight new T2D loci reaching genome-wide significance, which mapped in or near GLIS3, PEPD, FITM2-R3HDML-HNF4A, KCNK16, MAEA, GCC1-PAX4, PSMD6 and ZFAND3. GLIS3, which is involved in pancreatic beta cell development and insulin gene expression 1,2 , is known for its association with fasting glucose levels 3,4 . The evidence of an association with T2D for PEPD 5 and HNF4A 6,7 has been shown in previous studies. KCNK16 may regulate glucosedependent insulin secretion in the pancreas. These findings, derived from an east Asian population, provide new perspectives on the etiology of T2D.
T2D is a major public health problem with a rapidly rising global prevalence 8 . The development of T2D is influenced by diverse factors, and decades of epidemiological studies have linked obesity, hypertension and dyslipidemia with the risk of T2D 9 . It is also known that T2D has considerable heritability. Within only the last 3 years, genetic studies have produced a rapidly lengthening list of loci harboring disease-predisposing variations 10 . To date, genetic variants at 45 loci have been identified for T2D 10, 11 . Despite these advances toward a better understanding of the genetic basis of T2D, its heritability has not been fully explained 12 . In addition, most of the T2D loci were detected initially in population samples of European origin, with the exceptions of KCNQ1, UBE2E2 and C2CD4A-C2CD4B, which were first identified in studies of east Asian populations [13] [14] [15] . Additional efforts involving east Asian populations identified variants associated with T2D at the SPRY2, PTPRD and SRR loci 5, 16, 17 . However, these associations need more validation from additional studies of east Asians as well as in studies of other populations. A large meta-analysis in east Asians would be expected to identify new genetic associations and provide insights into T2D pathogenesis. In addition to differences in the allele frequencies between east Asians and Europeans, which may affect the power to detect associations in these populations, T2D epidemiology also differs considerably between European populations and east Asian populations. In east Asians, the rates of diabetes are often higher at lower average body mass indices (BMIs) 18 , suggesting that some different pathways may be involved in pathogenesis of T2D in east Asians and Europeans.
To discover new T2D loci, we conducted a three-stage association study in individuals of east Asian descent (Supplementary Fig. 1 ). We performed the stage 1 meta-analysis by combining eight T2D genome-wide association studies (GWAS) participating in the Asian Genetic Epidemiology Network (AGEN) consortium (6,952 cases and 11,865 controls) with association data for 2,626,356 imputed and genotyped autosomal SNPs, and we used the inverse-variance method Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians 6 8 VOLUME 44 | NUMBER 1 | JANUARY 2012 Nature GeNetics l e t t e r s for fixed effects for the statistical analyses (Supplementary Table 1 ). All imputed and genotyped SNPs (minor allele frequency (MAF) > 0.01) passed quality control filters in each of the eight stage 1 datasets prior to conducting the meta-analysis (Supplementary Table 2 ). The genomic control inflation factor (λ) for the meta-analysis was 1.046 (and was less than 1.062 for each of the individual studies), indicating that the results seen in stage 1 were probably not the result of population stratification (Supplementary Fig. 2) . Individuals from each component study that participated in stage 1 mainly clustered together with the samples from the CHB/JPT HapMap population in the principal component analysis plot (Supplementary Fig. 3) , further showing the similarity in ethnicity between the stage 1 samples. Most signals showing strong evidence for T2D associations were in known T2D genes (Fig. 1) . Stage 1 P values, odds ratios (ORs) and average risk allele frequencies for 45 previously reported T2D-associated SNPs are listed in Supplementary Table 3 .
After removing known T2D variants, we selected 297 SNPs from independent loci from the stage 1 meta-analysis based on our arbitrary inclusion criteria for in silico follow-up replication: meta-analysis P < 5 × 10 −4 (based on the divergence between the observed and expected P values on the quantile-quantile plot; Supplementary  Fig. 2 ), heterogeneity P > 0.01 and at least seven studies having been included in the meta-analysis (Supplementary Table 4 ). We took a total of 3,756 SNPs, including the 297 selected SNPs and their proxies (r 2 > 0.8 based on phase 2 CHB/JPT HapMap data), forward to stage 2 (in silico replication) in three independent GWAS (5,843 cases and 4,574 controls). After a meta-analysis that combined stage 1 and 2 data for 3,756 SNPs, we selected the 19 SNPs that showed the most compelling evidence for association (stage 1 and 2 combined P < 10 −5 ) (Supplementary Tables 1 and 2 ). This resulted in eight new T2D loci that reached genome-wide significance in the combined meta-analysis across all three stages ( Table 1 and Fig. 2) .
Three of these T2D-associated loci were previously associated with metabolic traits or related diseases or were suggestively associated with T2D. We detected one such locus within an intron of GLIS3, a gene that is highly expressed in islet beta cells. The coding product of this gene, a Krüppel-like zinc finger transcription factor, has been proposed as a key player in the regulation of pancreatic beta cell development and insulin gene expression 1, 2 . SNPs in high linkage disequilibrium (LD) with this locus have been implicated in association with type 1 diabetes (T1D) 19 and fasting plasma glucose 3 . The second such locus, on 19q13, is located in an intron of PEPD. Several SNPs (lead SNP: rs10425678) in this gene were previously associated with T2D in a Japanese population 5 . However, the SNP in PEPD identified in our study (rs3786897) is not in LD with those identified in the Japanese population (r 2 = 0.008, D′ = 0.143 between rs3786897 and rs10425678 based on phase 2 CHB/JPT HapMap data), and our GWAS data do not support an association for T2D with rs10425678 (P = 0.528). The third such signal is near FITM2-R3HDML-HNF4A. FITM2 may be involved in lipid droplet accumulation 20 , and the function of R3HDML is not known. Mutations in HNF4A cause maturity onset diabetes of the young type 1 (ref. 21) . Common variants in the P2 promoter region of this gene (rs1884613 and rs2144908) have been associated with T2D in a population-specific manner 6, 22 . The SNP near FITM2-R3HDML-HNF4A identified in our study (rs6017317) is not in strong LD with the HNF4A P2 promoter SNPs (r 2 = 0.23-0.25, D′ = 0.50-0.54 between rs6017317 and rs1884613 or rs2144908 based on phase 2 CHB/JPT HapMap data), indicating that rs6017317 is a new T2D signal in the 20q13.12 region where HNF4A resides.
The other five loci reaching genome-wide significance in our study have not previously been reported in the context of any metabolic traits, including the loci mapped in or near KCNK16, MAEA, GCC1-PAX4, PSMD6 and ZFAND3. KCNK16, which is expressed predominantly in the pancreas, encodes a potassium channel protein containing two pore-forming P domains 23 . In pancreatic β cells, potassium channels that are inhibited by ATP regulate glucosedependent insulin secretion. Among the variants in strong LD with the signal reaching genome-wide significance in KCNK16 (rs1535500) is rs11756091 (r 2 = 0.977, D′ = 1.0 based on phase 2 CHB/JPT HapMap data), which encodes a substitution of proline to histidine in two isoforms of KCNK16. This variant or others influencing KCNK16 may result in the defective regulation of potassium channel activity that contributes to the etiology of T2D 24 . MAEA encodes a protein that has a role in erythroblast enucleation and in the development of mature macrophages 25 . A gene-set analysis of the stage 1 P values using GSA-SNP 26 indicated that MAEA belongs to a group of genes that previously showed significant association with T2D and includes IDE, which is located at a known T2D susceptibility locus 27 (stage 1 P = 1.41 × 10 −7 for rs6583826 at the IDE locus in this study). The GRIP-domain-containing protein that is encoded by GCC1 might have a role in the organization of the trans-Golgi network, which is involved in membrane transport 28 . PAX4, which is only 30 kb away from GCC1, is a good candidate for T2D given its involvement in pancreatic islet development. PAX4 was recently implicated in a Japanese individual with maturity onset diabetes of the young 29 . The expression product of PSMD6, which acts as a regulatory subunit of the 26S proteasome, is probably involved in the ATP-dependent degradation of ubiquitinated proteins 30 . Although the function of ZFAND3 has not been fully elucidated, it is noteworthy that a member of the same gene family, ZFAND6, is present along with FAH at a previously detected T2D locus 31 . We examined whether eight new loci are potentially associated with T2D through an effect on obesity, as is the case with FTO 32 . All of the T2D association signals we initially detected remained after adjustment for BMI (Supplementary Table 6 ), indicating that the associations with T2D of these eight loci are not mediated through an effect on obesity.
In addition to the eight loci reaching genome-wide significance, we identified two loci showing moderate evidence (combined P < 10 −6 ) of association with T2D, including WWOX and CMIP loci ( Table 1) . We obtained the association results for these ten loci in GWAS data from up to 47,117 European samples generated by the DIAGRAM consortium (DIAGRAM+ is the current version of dataset) 31 . The red dots at each locus indicate the signals with P < 10 −6 detected in the genome-wide metaanalysis. A total of 1,934,619 SNPs that were present in at least five stage 1 studies were used to generate the plot.
l e t t e r s
The DIAGRAM-generated results for these loci indicated that three loci, including the FITM2-R3HDML-HNF4A (rs6017317: P = 1.47 × 10 −2 , OR = 1.07), CMIP (rs16955379: P = 3.33 × 10 −2 , OR = 1.20) and MAEA (using the proxy SNP for rs6815464, rs11247991 (r 2 = 0.96): P = 6.56 × 10 −3 , OR = 1.19) loci, were modestly associated with T2D, whereas a locus in GLIS3 (rs7041847: P = 6.43 × 10 −2 , OR = 1.04) was nominally associated with T2D. The direction of effect was consistent in four (PSMD6, PEPD, WWOX and KCNK16) of the six loci that were not replicated in DIAGRAM+ (Supplementary Table 5 ).
We analyzed the functional connections among the 10 new T2D genes and the 28 known T2D genes that we replicated in this study (Supplementary Table 3) using GRAIL 33 . The connection results highlighted notable biological functions for sets of genes within T2D-associated regions ( Supplementary Fig. 4 and Supplementary  Tables 7 and 8 ). For example, KCNK16 has strong connections with previously known T2D genes encoding potassium channels (KCNJ11 and KCNQ1), implying that is has a physiological role in the regulation of potassium transport in pancreatic cells.
We examined the association between each new T2D SNP and the expression of genes within 1 Mb of these SNPs by an expression quantitative trait locus (eQTL) analysis using the data from the MuTHER consortium. One SNP (rs3786897) in an intron of PEPD was highly associated with the mRNA expression of PEPD in the adipose tissue of 776 individuals of European ancestry (P eQTL = 2.14 × 10 −8 ) (Supplementary Table 9 ). However, this SNP did not show an association with T2D in populations of European ancestry, thus the importance of this finding is unclear.
We considered the possibility that autoimmune diabetes (rather than T2D) may be driving some of the signals that we observed. First, the cases from all the studies we examined predominantly had adult-onset diabetes (age of disease onset ≥30 years), and none of the clinically diagnosed subjects had T1D, which is defined by the presence of acute ketosis and the continuous requirement of insulin beginning within 1 year after diagnosis. Second, we researched the associations for all known T1D-associated variants in our dataset. Only a small number of loci showed association after this analysis (Supplementary Table 10 ). These results are in distinct contrast to those for known T2D-associated variants, many of which replicated in our study (Supplementary Table 3) , further suggesting that our findings are most relevant to T2D. Third, as variants close to the GLIS3 locus have been shown to be associated with T1D 19 , we examined the association between rs7041847 and diabetes in four studies (n = 8,383) in which individulas with positive glutamic acid decarboxylase (GAD) antibodies had been excluded (as individuals with T1D are positive for GAD antibodies, whereas individuals with T2D are not) (data not shown). In each study, the associations between this SNP and diabetes were the same as the association found when we included all the samples (meta-analysis P = 3.4 × 10 −4 , OR = 1.12). This finding, along with the fact that SNPs at the GLIS3 locus also show associations with fasting plasma glucose in nondiabetic adults 3 and in healthy children and adolescents 4 , is consistent with the hypothesis that SNPs at this locus may affect fasting glucose homeostasis rather than the immune system. Taken together, it is unlikely that a substantial proportion of the positive associations observed in our study were driven by autoimmune diabetes.
This study is the largest GWAS meta-analysis, to our knowledge, conducted for T2D in east Asians. Findings from this study highlight not only previously unknown biological pathways but also population-specific loci for T2D. The association of rs9470794 in ZFAND3 with T2D seems to be highly specific to east Asian populations (Supplementary Table 5) , whereas the association of The proxy SNP rs9930117 (r 2 = 1) was genotyped in the stage 3 CAGE study.
l e t t e r s rs11634397 near ZFAND6 seems to be specific to European populations (Supplementary Table 3 ). We observed a substantial difference in the risk allele frequencies of both loci between the two continental (Asian and European) populations (rs9470794: risk allele frequency (RAF) = 0.32 for the Asian CHB/JPT HapMap population compared to RAF = 0.12 for the European CEU HapMap population; rs11634397: RAF = 0.07 for CHB/JPT compared to RAF = 0.64 for CEU). Although these loci are related to T2D differently in the two populations (the ZFAND3 locus is specific to Asians, whereas the ZFAND6 locus to Europeans), these results lead to speculation that the broader A20 domain-containing zinc finger protein family has a role in the etiology of T2D. Additional population-specific T2D loci were also suggested by our analysis, for example, WWOX (rs17797882) (Supplementary Figure 2 Regional association plots for new T2D loci. a-j At the top, the positions of SNPs are shown, and in the middle, the regional association results from the genome-wide meta-analysis are shown. The trend test -log 10 P values are shown for SNPs distributed in a 0.8-Mb genomic region centered on the most strongly associated signal, which is depicted as a purple diamond for the stage 1 results and a red diamond for the combined stage 1, 2 and 3 results. At the bottom, the locations of known genes in the region are shown. The genetic information was from the Human Genome build hg18, and the LD structure was based on the 1000 Genomes Project JPT+CHB data (June 2010).
Note: Supplementary information is available on the Nature Genetics website.
